CAM2029 (octreotide subcutaneous depot), CAM2029 (octreotide subcutaneous depot)
HS-19-647
Phase 3 small_molecule active
Quick answer
CAM2029 (octreotide subcutaneous depot), CAM2029 (octreotide subcutaneous depot) for Acromegaly is a Phase 3 program (small_molecule) at Camurus AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Camurus AB
- Indication
- Acromegaly
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active